> ## Documentation Index
> Fetch the complete documentation index at: https://docs.getrivet.ca/llms.txt
> Use this file to discover all available pages before exploring further.

# BSL-23 — scoring and mean-score interpretation

> How to score the Borderline Symptom List, what the mean score means, and how to track borderline symptom severity across DBT work.

The BSL-23 is the short form of Bohus's Borderline Symptom List — the
self-report severity tracker used in DBT and similar borderline-focused
protocols to measure trajectory across treatment. It's descriptive, not
diagnostic. A high score doesn't make a BPD diagnosis; a downward trend
across sessions is the signal you're after.

Twenty-three items, one week look-back, free for academic and clinical
use under CC-BY.

## What it measures

Past-week severity of borderline-specific symptoms across seven
implicit domains:

* Self-perception
* Affect regulation
* Self-destructive impulses
* Dysphoria
* Loneliness and emptiness
* Intrusions
* Hostility

The 23 items don't map cleanly to seven distinct subscales — Bohus
designed the short form for a single severity total. Use the total
score and watch the trajectory.

## When to use it

* **Intake for borderline-focused work** to establish a severity
  baseline.
* **Every 2-4 weeks during DBT or other borderline protocols** to
  track trajectory.
* **Pre/post a discrete protocol phase** (DBT skills modules, brief
  DBT, modified EMDR for CPTSD).
* **Outcome documentation** at discharge.

## How clients fill it out

Twenty-three items rated 0-4 (Not at all → Very strong) over the past
week. Five to seven minutes. Reading level grade 7-8.

## Scoring and severity cutoffs

Sum of all 23 items. Range 0-92.

### Bands

| Total | Band (mean equivalent)  |
| ----- | ----------------------- |
| 0-12  | None to low (mean ≤0.5) |
| 13-35 | Mild (mean 0.6-1.5)     |
| 36-58 | Moderate (mean 1.6-2.5) |
| 59-81 | High (mean 2.6-3.5)     |
| 82-92 | Very high (mean ≥3.6)   |

Bands are derived from the canonical per-item mean thresholds in
Kleindienst 2020's BSL-23 validation work — the original instrument
is sometimes interpreted on a 0-4 mean scale rather than a sum, and
the Rivet bands translate the mean cuts back to the sum scale.

### Self-harm / suicidality items

Items 5 (self-harm thoughts), 7 (right to live), 12 (self-punishment),
and 18 (fascination with death) form a separate flagged subscale. Any
score ≥ 1 on any of these surfaces a "self-harm / suicidality /
death-fascination endorsed — clinical evaluation indicated" label on
the result.

<Warning>
  **The self-harm subscale flag is decision-support, not a complete
  risk assessment.** When any of items 5, 7, 12, or 18 are
  endorsed, do a direct risk conversation with the client and pair
  with the C-SSRS at intake and at any inflection point. The
  BSL-23 alone is not sufficient for risk stratification.
</Warning>

## Clinical change

BPD severity moves slowly. A 5-10 point drop across a 12-week
treatment period is in the range of effects reported in DBT outcome
literature. A one-band shift (e.g. high → moderate) over a full course
of treatment is the more clinically meaningful threshold for
documentation.

## Use note

BSL-23 is **descriptive**, not diagnostic. It tells you how severe
the borderline-spectrum experience is right now — it doesn't make a
BPD diagnosis. Positive borderline screening belongs with the
MSI-BPD or a structured clinical interview. Use BSL-23 once a
clinical frame is established to track severity over time.

## BSL-23 vs MSI-BPD

The BSL-23 is descriptive, not diagnostic, and that is a deliberate design
choice rather than a limitation. It has no cutoff that says "borderline";
it produces a severity number for the past week that you can watch move
across a course of DBT.

Screening is the [MSI-BPD](/clinical-templates/screening/msi-bpd)'s job —
ten yes/no items against the DSM criteria with a cutoff at 7, and a
positive result meaning a structured interview is warranted.

So they sit in sequence rather than competition: MSI-BPD to decide whether
this is the right formulation, BSL-23 to track it once you're working.
Using the BSL-23 as a screen would be reading a number it isn't producing.

## Is it free to use?

**Yes.** Published under a Creative Commons attribution licence by Bohus and colleagues.

## Citation

Bohus, M., Kleindienst, N., Limberger, M. F., Stieglitz, R. D.,
Domsalla, M., Chapman, A. L., Steil, R., Philipsen, A., & Wolf, M.
(2009). "The short version of the Borderline Symptom List
(BSL-23): development and initial data on psychometric properties."
*Psychopathology,* 42(1): 32-39.

CC-BY academic/clinical use per Bohus 2009. Verbatim canonical
wording.

## When not to use it

* **You're doing a borderline differential** without an established
  frame. Use MSI-BPD or a structured interview first.
* **The client is under 18.** BSL-23 is validated in adult samples.
* **You want a measure of emotion regulation specifically.** Use
  the DERS-18 instead — BSL-23 is broader.

## Related articles

<CardGroup cols={2}>
  <Card title="DERS-18" icon="chart-column" href="/clinical-templates/specialized/ders-18">
    Emotion regulation difficulties — narrower than BSL-23 and
    closer to the DBT skills frame.
  </Card>

  <Card title="ITQ" icon="brain" href="/clinical-templates/screening/itq">
    Complex PTSD measure for clients whose presentation crosses
    BPD and CPTSD.
  </Card>

  <Card title="C-SSRS" icon="triangle-exclamation" href="/clinical-templates/clinician-administered/c-ssrs">
    Suicide risk screener — pair with BSL-23 when self-harm items
    flag.
  </Card>
</CardGroup>
